Clinical Trials Browser

Phase 2 × Completed × pyrotinib × Clear all

NCT02834936 2025-08-28

A Clinica Study of Pyrotinib in Patients of Advanced Non-Small Cell Lung Cancer With HER2 Mutation

Phase 2 Completed

Non Small Cell Lung

NCT03735966 2022-12-01

Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Docetaxel and Carboplatin in HER2 Positive Breast Cancer Patients.

Phase 2 Completed

HER2 Positive Breast Cancer